Paper589672
On the varied biologic effects of interferon.
Gresser I. Cell Immunol, 1977. Cited by 371 papers, by iCite.
Cite this record
ConductScience Library. On the varied biologic effects of interferon. Papers, record 589672. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/589672
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Antibody Formation | |
| Cell Division | |
| Cell Membrane |
Source PubMed
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 371 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34734110 | Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress. | Adv Ther (Weinh) | 2021 | https://conductscience.org/library/papers/34734110 | PubMed |
| 12498390 | Evidence for the causal role of endogenous interferon-alpha/beta in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms. | Clin Exp Metastasis | 2002 | https://conductscience.org/library/papers/12498390 | PubMed |
| 8205559 | A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-alpha 2a in patients with advanced malignant melanoma. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8205559 | PubMed |
| 7276828 | In vitro generation of human cytotoxic lymphocytes by virus. Viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon. | J Exp Med | 1981 | https://conductscience.org/library/papers/7276828 | PubMed |
| 6865941 | Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetase. | Mol Cell Biol | 1983 | https://conductscience.org/library/papers/6865941 | PubMed |
| 6678308 | Interferon effects on multiplication, cytoplasmic protein and GFAP content, and morphology in human glioma cells. | J Neurooncol | 1983 | https://conductscience.org/library/papers/6678308 | PubMed |
| 6620465 | Blockage of antiviral induction of interferon by homologous cell biochemical activity: effect of chicken embryo fibroblast mitotic cell cycle phases on Sindbis virus growth. | J Virol | 1983 | https://conductscience.org/library/papers/6620465 | PubMed |
| 6611523 | Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects. | Neurosurg Rev | 1984 | https://conductscience.org/library/papers/6611523 | PubMed |
| 6444662 | Interferon as a mediator of human lymphocyte suppression. | J Exp Med | 1980 | https://conductscience.org/library/papers/6444662 | PubMed |
| 6384555 | Porcine leukocyte cellular subsets sensitive to African swine fever virus in vitro. | J Virol | 1984 | https://conductscience.org/library/papers/6384555 | PubMed |
| 6371020 | Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization. | J Cell Biol | 1984 | https://conductscience.org/library/papers/6371020 | PubMed |
| 6243926 | Antagonism in action between mouse or human interferon and platelet growth factor. | Arch Virol | 1980 | https://conductscience.org/library/papers/6243926 | PubMed |
| 6198116 | Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6198116 | PubMed |
| 6195717 | Interferon and reversion of the transformed phenotype. | Surv Immunol Res | 1982 | https://conductscience.org/library/papers/6195717 | PubMed |
| 6192149 | Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6192149 | PubMed |
| 6187920 | Interferon therapy and immunity. | J R Soc Med | 1983 | https://conductscience.org/library/papers/6187920 | PubMed |
| 6181288 | Interferons and bacterial infections. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/6181288 | PubMed |
| 6178542 | Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6178542 | PubMed |
| 6178224 | Advances in interferon research - Medical Staff Conference. | West J Med | 1982 | https://conductscience.org/library/papers/6178224 | PubMed |
| 6175574 | Susceptibility of bovine macrophages to infectious bovine rhinotracheitis virus infection. | Infect Immun | 1982 | https://conductscience.org/library/papers/6175574 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/589672
GET https://conductscience.org/api/papers/v1/589672/cited_by?page=2